View the full list of references supporting this article in European Pharmaceutical Review, Issue 02 2026.

References

1. FDA Proposes Rule to Modernize Drug Manufacturing Registration. [Internet] FDA. 2026. Available from: https://www.fda.gov/news-events/press-announcements/fda-proposes-rule-modernize-drug-manufacturing-registration

2. von der Leyen H, Delgado J, Mazouz C, et al. Implementation of A Quality Management System for Decentralized Manufacturing of Cell And Gene Therapy Products - Technical And Regulatory Considerations. Front Med (Lausanne). 2025;12:1591751.

3. Hort S, Herbst L, Bäckel N, et al. Toward Rapid, Widely Available Autologous CAR-T Cell Therapy – Artificial Intelligence And Automation Enabling The Smart Manufacturing Hospital. Front Med. 2022;9:913287.

4. Auclair JR, Joung J, Singh MA, et al. Artificial Intelligence and the Transformation Of Cell and Gene Therapy Development. Pharmaceutics. 2026;18(3):356.